Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Amgen’s postmenopausal osteoporosis drug wins FDA panel backing

An advisory panel to the U.S. FDA said benefits of Amgen Inc.’s osteoporosis treatment for postmenopausal women at high risk for fracture outweighed the monthly injection’s risks.

Read More »

FDA Advisory Committee Recommends AcelRx’s Opioid Drug Dsuvia

The U.S. Food and Drug Administration’s Anesthetic and Analgesic Drug Products Advisory Committee voted to recommend AcelRx Pharmaceuticals’ Dsuvia to manage moderate-to-severe pain.

Read More »

FDA panel backs gene therapy for rare blindness form

Spark Therapeutics Inc.’s experimental gene therapy for a rare form of blindness improves vision and should be approved, advisers to the Food and Drug Administration concluded, paving the way for the first U.S. gene therapy for an inherited disease.

Read More »

‘Impressed’ FDA panel unanimously recommends GSK shingles vaccine

A U.S. Food and Drug Administration advisory panel voted 11-0 that the safety and efficacy of GlaxoSmithKline’s Shingrix shingles vaccine warrants approval for its use in adults aged 50 and over.

Read More »

FDA Advisory Committee Unanimously Recommends Approval of Mylan and Biocon’s Proposed Biosimilar Trastuzumab

Mylan N.V. and Biocon Ltd. announced that the U.S. Food and Drug Administration Oncologic Drugs Advisory Committee recommended approval of the companies’ proposed biosimilar trastuzumab.

Read More »

FDA Panel Unanimously Endorses Novartis’ CAR-T Leukemia Drug

A U.S. Food and Drug Administration advisory panel unanimously recommended approval of Novartis AG’s CAR-T therapeutic, CTL019 (tisagenlecleucel), for B-cell acute lymphoblastic leukemia.

Read More »

Pfizer Biosimilar Recommended for U.S. Approval

The U.S. FDA Oncologic Drugs Advisory Committee recommended approval of Pfizer’s proposed epoetin alfa biosimilar across all indications.

Read More »

FDA panel backs Valeant psoriasis drug with risk program

Valeant Pharmaceuticals International Inc.’s experimental drug to treat the skin disorder psoriasis should be approved as long as certain measures are put in place to mitigate the risk of suicide.

Read More »

U.S. panel backs approval for infectious diarrhea drug

Merck & Co.’s experimental drug to treat the most common cause of hospital-associated infectious diarrhea warrants approval, an advisory panel to the U.S. FDA said.

Read More »

FDA panel backs approval of Pfizer’s opioid painkiller

A U.S. advisory panel recommended approval of Pfizer Inc’s long-acting opioid painkiller Troxyca ER, saying it dulls pain and its design could deter abuse by addicts in search of a quick high.

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

June 2019 Focus: Payer access, biotech/biopharma, DTC, rare diseases, and more!

Subscribe

Ad Right Bottom